In the year of the 30th anniversary of the National Patent System of the Republic of Kazakhstan, the leading institute of the country, the RSE “Research Institute for Biological Safety Problems” was recognized as the best enterprise in the field of intellectual property by the World Intellectual Property Organization.
RSE “Research Institute for Biological Safety Problems” is a leading center in Kazakhstan in the development of new modern vaccines and diagnostic drugs.
Unique and advanced developments of the Institute, protected by more than 240 patents, 12 utility models and 8 trademarks, including the world-famous vaccines QazVac against Covid-19, Neethling-RIBSP against Lumpy skin disease, NISKHI against sheep smallpox and others, are highly appreciated and recognized by the world community.
